Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mallinckrodt plc
(NY:
MNK
)
N/A
UNCHANGED
Last Price
Updated: 8:00 PM EDT, Aug 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mallinckrodt plc
Mallinckrodt Plc (NYSE: MNK) Investor Alert: Deadline in Lawsuit on September 5, 2023
September 05, 2023
San Diego, CA -- (SBWIRE) -- 09/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on September 5, 2023 in the lawsuit filed for certain investors of Mallinckrodt plc (NYSE:...
Via
SBWire
Topics
Lawsuit
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)
September 01, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Addiction Treatment Market May See New Emerging Trends: Novartis, Pfizer, Sanofi
August 17, 2023
Pune, Maharashtra -- (SBWIRE) -- 08/17/2023 -- 2023-2031 Report on Global Addiction Treatment Market by Player, Region, Type, Application and Sales Channel is the latest research study released by HTF...
Via
SBWire
Mallinckrodt Plc (NYSE: MNK) Investor Alert: Lawsuit Alleges False and Misleading Statements
August 10, 2023
San Diego, CA -- (SBWIRE) -- 08/10/2023 -- An investor, who purchased shares of Mallinckrodt plc (NYSE: MNK), filed a lawsuit in the U.S. y over alleged violations of Federal Securities Laws by...
Via
SBWire
Topics
Lawsuit
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)
July 25, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)
July 24, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors
July 21, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors
July 20, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors
July 20, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors
July 19, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors
July 19, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors
July 14, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors with Over $1 Million in Losses to Secure Counsel Before Important Deadline in Securities Class Action – MNK, MNKPF
July 13, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Calling All Mallinckrodt plc (MNK) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!
July 13, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Mallinckrodt plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MNK, MNKPF
July 12, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Bankruptcy
Lawsuit
Calling All Mallinckrodt plc (MNK) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!
July 12, 2023
From
Bronstein, Gewirtz & Grossman
Via
Business Wire
Post-operative Cataract Surgery Inflammation Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Mallinckrodt Pharma, Salix Pharma, GlaxoSmithKline
June 20, 2023
Via
AB Newswire
Opioid Use Disorder Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight | Key Players – Indivior, Alkermes, Orexo AB, Mallinckrodt, Braeburn Pharmaceutical
June 16, 2023
Via
AB Newswire
Opioid Overdose Market expected to rise | Companies – Purdue Pharmaceuticals L.P., Titan Pharmaceuticals, Inc., Pfizer Inc., Mallinckrodt, Pfizer Inc., Assertio Holdings, expected to boost the market
June 12, 2023
Via
AB Newswire
Buxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment Scheme
April 28, 2023
From
The Buxton Helmsley Group, Inc.
Via
Business Wire
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK
April 13, 2023
WHY: New York, NY - (NewMediaWire) - April 13, 2023 - Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Mallinckrodt...
Via
TheNewswire.com
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK
April 13, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK
April 02, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Mallinckrodt plc and Encourages Investors with Losses to Contact the Firm
March 21, 2023
From
The Schall Law Firm
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Mallinckrodt plc and Encourages Investors with Losses to Contact the Firm
March 20, 2023
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation – MNK
March 20, 2023
From
Rosen Law Firm
Via
Business Wire
Nanomedicine Market Size & Share Report 2022 : Reach at US$ 238.4 Bn and Grow at Healthy CAGR 10.1% During Forecast Period 2022-2028
December 06, 2022
"Emerging innovative technologies for drug delivery, the benefits of nanomedicine in various healthcare applications, and the increase in the demand for safe and inexpensive treatments drive the growth...
Via
SBWire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today